[6][7] In 2013 SBMT Board and Members defined Brain Mapping as the study of the anatomy and function of the brain and spinal cord through the use of imaging (including intra-operative, microscopic, endoscopic and multi-modality imaging), immunohistochemistry, molecular & optogenetics, stem cell and cellular biology, engineering (material, electrical and biomedical), neurophysiology and nanotechnology.
The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare.
The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine.
[8] SBMT played a significant role in the formulation, planning and execution of Obama's BRAIN Initiative and in 2013 pioneered the G20+ World Brain Mapping & Therapeutic Initiative, which is aimed at creating a global consortium focusing on integration of nanotechnology, imaging, cellular/stem cell therapeutics, Information Technology (IT) and devices (this approach called NanoBioElectronics) in Brain Mapping.
[9] Collaborating partners also include: Australian Government and Australian Bio Tech (collections of 650 Australasia biotech firms), Canadian government and scientists, Turkish scientists, more than 200 universities and research institutions across the world.